LINC00511 and cholangiocarcinoma: Our research demonstrated that LINC00511 was significantly upregulated in CCA, aligning with other studies that had found increased expression levels of LINC00511 in malignancies such as non‐small‐cell lung cancer, liver cancer, glioma, and breast cancer.49, 50, 51